- Home
- PULM vs AMS Comparison
PULM vs AMS Comparison
Compare PULM & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- AMS
- Stock Information
- Founded
- PULM 2003
- AMS 1980
- Country
- PULM United States
- AMS United States
- Employees
- PULM N/A
- AMS N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- PULM Health Care
- AMS Health Care
- Exchange
- PULM Nasdaq
- AMS Nasdaq
- Market Cap
- PULM 18.3M
- AMS 17.2M
- IPO Year
- PULM N/A
- AMS N/A
- Fundamental
- Price
- PULM $4.89
- AMS $2.41
- Analyst Decision
- PULM
- AMS
- Analyst Count
- PULM 0
- AMS 0
- Target Price
- PULM N/A
- AMS N/A
- AVG Volume (30 Days)
- PULM 9.6K
- AMS 3.7K
- Earning Date
- PULM 11-07-2025
- AMS 11-12-2025
- Dividend Yield
- PULM N/A
- AMS N/A
- EPS Growth
- PULM N/A
- AMS N/A
- EPS
- PULM N/A
- AMS N/A
- Revenue
- PULM $369,000.00
- AMS $29,251,000.00
- Revenue This Year
- PULM N/A
- AMS $5.06
- Revenue Next Year
- PULM $134.88
- AMS N/A
- P/E Ratio
- PULM N/A
- AMS N/A
- Revenue Growth
- PULM N/A
- AMS 26.61
- 52 Week Low
- PULM $1.96
- AMS $2.27
- 52 Week High
- PULM $10.40
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- PULM 45.65
- AMS 43.71
- Support Level
- PULM $4.70
- AMS $2.39
- Resistance Level
- PULM $5.19
- AMS $2.51
- Average True Range (ATR)
- PULM 0.15
- AMS 0.07
- MACD
- PULM 0.07
- AMS -0.01
- Stochastic Oscillator
- PULM 44.44
- AMS 10.00
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.